HLS Therapeutics to Host Annual Shareholder Meeting
June 15 2018 - 5:30AM
PR Newswire (Canada)
TORONTO, June 15, 2018 /CNW/ - HLS Therapeutics Inc.
("HLS" or the "Company") (TSXV: HLS) announces details of its
upcoming Annual Meeting of Shareholders.
Date:
|
Friday June 22,
2018
|
|
|
Time:
|
10:00 a.m.
ET
|
|
|
Location:
|
Blake, Cassels &
Graydon LLP
199 Bay
Street
Commerce Court West,
Suite 4000
Toronto, Ontario M5L
1A9
|
About HLS Therapeutics Inc.
HLS (TSXV: HLS) is a specialty pharmaceutical company focused on
the acquisition and commercialization of late-stage development,
commercial-stage promoted and established, branded pharmaceutical
products in the North American markets. HLS's focus is on products
targeting the central nervous system and cardiovascular therapeutic
areas. HLS's management team is comprised of seasoned
pharmaceutical executives with a strong track record of success in
these therapeutic areas and at managing products in each of these
lifecycle stages.
Neither the TSX Venture Exchange nor its regulation services
provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE HLS Therapeutics Inc.
Copyright 2018 Canada NewsWire
Hls Therapeutics (TSXV:HLS)
Historical Stock Chart
From May 2024 to Jun 2024
Hls Therapeutics (TSXV:HLS)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Hls Therapeutics (TSX Venture Exchange): 0 recent articles
More HLS Therapeutics Inc. News Articles